🇪🇸 Spain Country × Condition
advanced solid tumor Clinical Trials in Spain
Active clinical trials for advanced solid tumor with research sites in Spain. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇪🇸 Spain
Active Trials in Spain (3)
NCT07414836 Phase 1
Recruiting
A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors
Enrollment
84 pts
Country
🇪🇸 Spain
BeOne Medicines
View Trial → NCT07213830 Phase 1, Phase 2
Recruiting
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
Enrollment
102 pts
Country
🇪🇸 Spain
Ipsen
View Trial → NCT05765851 Phase 1
Recruiting
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
Enrollment
108 pts
Country
🇪🇸 Spain
Daiichi Sankyo
View Trial → Frequently Asked Questions
How many advanced solid tumor clinical trials are active in Spain?
There are currently 3 active clinical trials for advanced solid tumor with sites in Spain, of which 3 are actively recruiting patients.
How can I join a advanced solid tumor clinical trial in Spain?
To join a advanced solid tumor clinical trial in Spain, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Spain directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are advanced solid tumor trials in Spain?
Active advanced solid tumor trials in Spain span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology